Biomarkers in systemic sclerosis

被引：66
|
作者：
Castro, Susan V. [1 ]
Jimenez, Sergio A. [1 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA
来源：
BIOMARKERS IN MEDICINE | 2010年 / 4卷 / 01期
关键词：
biomarker; endothelial cells; fibrosis; pulmonary artery hypertension; pulmonary fibrosis; scleroderma; systemic sclerosis; TGF-beta; ENDOTHELIAL GROWTH-FACTOR; PULMONARY ARTERIAL-HYPERTENSION; SOLUBLE ADHESION MOLECULES; INTERSTITIAL LUNG-DISEASE; VON-WILLEBRAND-FACTOR; COLLAGEN DEGRADATION-PRODUCTS; OLIGOMERIC MATRIX PROTEIN; IN-SITU EXPRESSION; SERUM-LEVELS; NATRIURETIC PEPTIDE;
D O I：
10.2217/BMM.09.79
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Systemic sclerosis is an autoimmune inflammatory disorder of unknown etiology characterized by pronounced fibroproliferative alterations in the microvasculature, and frequent cellular and humoral immunity abnormalities, culminating in a severe and often progressive fibrotic process. Numerous biomarkers reflecting the three main pathogenetic mechanisms in systemic sclerosis have been described; however, aside from several disease-specific autoantibodies, other biomarkers have not been thoroughly validated and require further study. Thus, there is an unmet need for validated biomarkers for diagnosis, disease classification, and evaluation of organ involvement and therapeutic response in systemic sclerosis.
引用
收藏
页码：133 / 147
页数：15
相关论文
共 50 条
  • [31] Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
    Lota, Harpreet K.
    Renzoni, Elisabetta A.
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
  • [32] Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment
    Arron, Joseph R.
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (06) : 480 - 485
  • [33] Endothelial Microparticles As Biomarkers Of Pulmonary Hypertension In Systemic Sclerosis
    Lammi, M. R.
    Saketkoo, L. A.
    Okpechi, S.
    Wyczechowska, D.
    Bauer, N.
    Pyakurel, K.
    Ghonim, M.
    Saito, S.
    Jaligam, V.
    DeBoisblanc, B.
    Boulares, A. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [34] Biomarkers in systemic sclerosis: Their potential to predict clinical courses
    Hasegawa, Minoru
    JOURNAL OF DERMATOLOGY, 2016, 43 (01): : 29 - 38
  • [35] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease
    Matson, S.
    Dvorkin, D.
    Fischer, A.
    Achtar-Zadeh, N.
    Wolters, P. J.
    Lee, J. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [36] BIOMARKERS FOR EARLY DIAGNOSIS OF CARDIAC INVOLVEMENT IN SYSTEMIC SCLEROSIS
    Tifi, Priscilla
    Pala, Barbara
    Tempestini, Federica
    Cristiano, Ernesto
    Bocci, Alessandro
    Rosato, Edoardo
    Salerno, Gerardo
    Romaniello, Antonella
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [37] Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
    Affandi, Alsya J.
    Radstake, Timothy R. D. J.
    Marut, Wioleta
    SEMINARS IN IMMUNOPATHOLOGY, 2015, 37 (05) : 475 - 487
  • [38] Prediction of Fibrosis Progression in Systemic Sclerosis By Collagen Biomarkers
    Dobrota, Rucsandra
    Jordan, Suzana
    Juhl, Pernille
    Maurer, Britta
    Wildi, Lukas
    Bay-Jensen, Anne-C.
    Karsdal, Morten
    Siebuhr, Anne Sofie
    Distler, Oliver
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [39] Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review
    Fioretto, Bianca Saveria
    Rosa, Irene
    Matucci-Cerinic, Marco
    Romano, Eloisa
    Manetti, Mirko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [40] NAILFOLD VIDEOCAPILLAROSCOPY AND SERUM VEGF AS BIOMARKERS OF SEVERITY IN SYSTEMIC SCLEROSIS?
    De Santis, M.
    Cavaciocchi, F.
    Crotti, C.
    Ceribellil, A.
    Laria, A.
    Marasini, B.
    Massarotti, M. S.
    Selmi, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S74 - S74
12345